PMAA nanogel controllably releases anti-IL-1β IgY for treating allergic rhinitis

Volume: 26, Issue: 8
Published: Jul 10, 2019
Abstract
Intranasal glucocorticoid spray is the preferred method to treat allergic rhinitis. However, due to the instantaneous high drug concentration, there are still some side effects, such as nasal dryness, nasal bleeding and even systemic effect of glucocorticoid. Herein, a novel biocompatible poly(methacrylic acid) (PMAA) nanogel was synthesized and used to load anti-IL-1β IgY (IgY) for treating allergic rhinitis induced by ovalbumin. The results...
Paper Details
Title
PMAA nanogel controllably releases anti-IL-1β IgY for treating allergic rhinitis
Published Date
Jul 10, 2019
Volume
26
Issue
8
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.